MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5588/ijtld.18.0651

Медицинская библиотека · The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019

Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.

Hughes J, Reuter A, Chabalala B, Isaakidis P, Cox H, Mohr E

СтатьяПеревод требует повторной обработки

Аннотация

SETTING

Patients with rifampicin-resistant tuberculosis (RR-TB) in the township of Khayelitsha, South Africa, were offered delamanid (DLM) within a decentralised RR-TB treatment programme.

OBJECTIVE

To describe adverse events (AEs) among HIV-positive and negative people receiving DLM for RR-TB in a programmatic setting.

DESIGN

Patients were followed up monthly for blood, electrocardiography and clinical monitoring and AEs were assessed for severity grade, seriousness and relationship to DLM.

RESULTS

Fifty-eight patients (55% male; median age 35 years, interquartile range [IQR] 28-42) started DLM; 46 (79%) were HIV-positive, median CD4 count 173 cells/mm³ (IQR 70-294). Fifty (86%) patients experienced ≥1 new or worsening AE after starting DLM, most commonly vomiting, QTcB >450 ms and/or myalgia. Serious and/or severe AEs were experienced by 22 (38%) patients; three HIV-positive patients died (not related to DLM). HIV status was not significantly associated with number (P = 0.089) or severity/seriousness (P = 0.11) of AEs during exposure to DLM. Two (3%) patients had DLM withdrawn due to AEs.

CONCLUSION

AEs during RR-TB treatment, both before and during DLM exposure, were common, with relatively few serious/severe AEs considered related to DLM and no significant association with HIV status. Clinical and electrocardiography monitoring should be prioritised in the first two months after starting DLM.

Для цитирования: Hughes J, Reuter A, Chabalala B, Isaakidis P, Cox H, Mohr E. Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2019. DOI: 10.5588/ijtld.18.0651.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.